Neo Ivy Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Buy |
+90,364
| New | +$810K | 0.26% | 136 |
|
|
2022
Q4 | $188K | Buy |
+16,386
| New | +$188K | 0.13% | 231 |
|
|
2022
Q2 | – | Sell |
-466
| Closed | -$8K | – | 407 |
|
|
2022
Q1 | $8K | Buy |
+466
| New | +$8K | 0.01% | 440 |
|
|
2021
Q3 | – | Sell |
-17,543
| Closed | -$277K | – | 465 |
|
|
2021
Q2 | $277K | Buy |
17,543
+3,084
| +21% | +$48.7K | 0.28% | 134 |
|
|
2021
Q1 | $147K | Buy |
+14,459
| New | +$147K | 0.16% | 198 |
|